Home LiteratureArticle Details
PMID: 18071589 Published · epublish English

Concerted transcriptional regulation by BRCA1 and COBRA1 in breast cancer cells.

International journal of biological sciences ·Vol. 3 ·No. 7 ·2008-02-29

Aiyar Sarah E, Cho HyungJun, Lee Jae, Li Rong

Abstract

Cofactor of BRCA1 (COBRA1) was first identified as a protein that binds to the breast cancer susceptibility gene product BRCA1. COBRA1 modulates estrogen-dependent and independent transcription and suppresses the growth of breast cancer cells. Its expression is significantly reduced in metastatic and recurrent breast cancer, pointing to a tumor suppressor function in breast cancer development. In light of these initial implications of COBRA1 in human breast cancer, the current investigation sought to obtain more direct functional evidence that links COBRA1 with BRCA1 in transcriptional regulation in breast cancer cells. Small hairpin RNA (shRNA)-mediated gene knockdown and gene expression microarray were used to study the impact of COBRA1 and BRCA1 on global transcription in the same breast cancer cell background. The gene expression profiling study in tissue culture cells uncovers a significant overlap of COBRA1- and BRCA1-regulated genes, many of which have been previously implicated in breast cancer progression. The data shown herein support the notion that COBRA1 and BRCA1 may engage in common gene regulatory pathways to suppress breast cancer progression.

Keywords
BRCA1 COBRA1 breast cancer. shRNA knockdown transcription regulation
Article Info
Journal
International journal of biological sciences
Abbr.
Int J Biol Sci
Published
2008-02-29
Indexed
2007-12-11
Updated
2016-10-19
Language
English
Country/Region
Australia
NLM ID
101235568
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com